BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sgouros G. Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters. Semin Nucl Med 2020;50:124-32. [PMID: 32172797 DOI: 10.1053/j.semnuclmed.2019.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Sgouros G, Frey E, Du Y, Hobbs R, Bolch W. Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box. Eur J Nucl Med Mol Imaging 2021. [PMID: 34782911 DOI: 10.1007/s00259-021-05583-x] [Reference Citation Analysis]
2 Mokoala K, Lawal I, Lengana T, Kgatle M, Giesel FL, Vorster M, Sathekge M. PSMA Theranostics: Science and Practice. Cancers (Basel) 2021;13:3904. [PMID: 34359805 DOI: 10.3390/cancers13153904] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Sarnelli A, Belli ML, Azzali I, Loi E, Severi S, Strigari L. Alpha-Emitter Radiopharmaceuticals and External Beam Radiotherapy: A Radiobiological Model for the Combined Treatment. Cancers (Basel) 2022;14:1077. [PMID: 35205825 DOI: 10.3390/cancers14041077] [Reference Citation Analysis]
4 Griffith DM, Li H, Werrett MV, Andrews PC, Sun H. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles. Chem Soc Rev 2021;50:12037-69. [PMID: 34533144 DOI: 10.1039/d0cs00031k] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wahl RL, Sgouros G, Iravani A, Jacene H, Pryma D, Saboury B, Capala J, Graves SA. Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns. J Nucl Med 2021;62:23S-35S. [PMID: 34857619 DOI: 10.2967/jnumed.121.262751] [Reference Citation Analysis]
6 Murray I, Flux G. Applying radiobiology to clinical molecular radiotherapy. Nucl Med Biol 2021;100-101:1-3. [PMID: 34091132 DOI: 10.1016/j.nucmedbio.2021.05.005] [Reference Citation Analysis]
7 Zaid NRR, Kletting P, Winter G, Prasad V, Beer AJ, Glatting G. A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice. Pharmaceutics 2021;13:2132. [PMID: 34959413 DOI: 10.3390/pharmaceutics13122132] [Reference Citation Analysis]
8 Miederer M. Alpha emitting nuclides in nuclear medicine theranostics. Nuklearmedizin 2022;61:273-9. [PMID: 34624903 DOI: 10.1055/a-1650-9995] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sathekge MM, Bouchelouche K. Letter from the Editors. Semin Nucl Med 2020;50:115-7. [PMID: 32172794 DOI: 10.1053/j.semnuclmed.2020.02.014] [Reference Citation Analysis]
10 Sathekge MM, Bouchelouche K. Letter from the Editors. Seminars in Nuclear Medicine 2022;52:91-3. [DOI: 10.1053/j.semnuclmed.2022.01.001] [Reference Citation Analysis]
11 Olguin E, President B, Ghaly M, Frey E, Sgouros G, Bolch WE. Specific absorbed fractions and radionuclide S-values for tumors of varying size and composition. Phys Med Biol 2020;65:235015. [PMID: 32992308 DOI: 10.1088/1361-6560/abbc7e] [Reference Citation Analysis]
12 Park EA, Graves SA, Menda Y. The Impact of Radiopharmaceutical Therapy on Renal Function. Seminars in Nuclear Medicine 2022. [DOI: 10.1053/j.semnuclmed.2022.02.004] [Reference Citation Analysis]